Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Therapix Biosciences Ltd ADR TRPXY

Therapix Biosciences Ltd is a specialty clinical-stage pharmaceutical company. It is engaged in developing several innovative immunotherapy products and it owns patents in the immunotherapy field. It is focused on creating and enhancing a portfolio of technologies and assets based on cannabinoid pharmaceuticals. The operating segments of the group are Development of drugs based on cannabinoid molecules to be approved by an official regulatory authority (the Company's operation); and Pain clinic


OTCPK:TRPXY - Post by User

Comment by Fundy13on Dec 21, 2018 9:02am
60 Views
Post# 29145252

RE:RE:Deal is off

RE:RE:Deal is offThey had to terminate the deal in order to start talking with other companies.  They were already in negotiations with CURE so I am sure they will start those again.
The stock has already dropped back to pre deal levels so not expecting any further chance in value.
The bid and ask actually went up slightly after the news.  I think it is good to just have this done so they can move on.  They also now get another $500,000 debt  at 5% interest rate convertable to shares at $7.  Pretty confident we will at least get back up to the $7 mark, likely higher with a new deal or partner.
<< Previous
Bullboard Posts
Next >>